Developments Bioxytran signs NDA with UGA to evaluate galectin antagonist for bird flu Bioxytran (QTCQB:BIXT) announced that it has signed a non-disclosure agreement (NDA) with the board of regents of the University System of Georgia, University of Georgia (UGA), to collaborate on evaluating its galectin... March 19, 2025